Search Results - "MacGrogan, Gaëtan"

Management of radial scars/complex sclerosing lesions of the breast diagnosed on vacuum‐assisted large‐core biopsy: is surgery always necessary?

Authors: Bacci, Julia MacGrogan, Gaëtan Alran, Léonie et al.

Source: Histopathology. Dec2019, Vol. 75 Issue 6, p900-915. 16p. 7 Diagrams, 5 Charts.

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer.

Authors: Bellera, Carine A. MacGrogan, Gaëtan Debled, Marc et al.

Source: BMC Medical Research Methodology. 2010, Vol. 10, p20-31. 12p.

NearSense – Advances Towards a Silicon-Based Terahertz Near-Field Imaging Sensor for Ex Vivo Breast Tumour Identification.

Authors: Mavarani, Laven Hillger, Philipp Bücher, Thomas et al.

Source: Frequenz; 2018, Vol. 72 Issue 3/4, p93-99, 7p

Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude.

Authors: Debled, Marc MacGrogan, Gaëtan Breton-Callu, Christelle et al.

Source: European Journal of Cancer. Apr2015, Vol. 51 Issue 6, p697-704. 8p.

Prognostic Factors of Early Distant Recurrence in Hormone Receptor-positive, Postmenopausal Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy.

Authors: Debled, Marc MacGrogan, Gaëtan Brouste, Véronique et al.

Source: Cancer (0008543X). Jun2007, Vol. 109 Issue 11, p2197-2204. 8p. 6 Charts.

Terahertz refractive index-based morphological dilation for breast carcinoma delineation.

Authors: Cassar, Quentin Caravera, Samuel MacGrogan, Gaëtan et al.

Source: Scientific Reports. 3/19/2021, Vol. 11 Issue 1, p1-16. 16p.

Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers.

Authors: Bigarré, Célestin Bertucci, François Finetti, Pascal et al.

Source: Computer Methods & Programs in Biomedicine; Apr2023, Vol. 231, pN.PAG-N.PAG, 1p

Label-Free Observation of Micrometric Inhomogeneity of Human Breast Cancer Cell Density Using Terahertz Near-Field Microscopy.

Authors: Okada, Kosuke Cassar, Quentin Murakami, Hironaru et al.

Source: Photonics; May2021, Vol. 8 Issue 5, p151, 1p

Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations.

Authors: Rouault, Audrey Banneau, Guillaume MacGrogan, Gaëtan et al.

Source: PLoS ONE. Dec2012, Vol. 7 Issue 12, p1-12. 12p.

Breast hamartoma: reassessment of an under-recognised breast lesion.

Authors: Alran, Léonie Chamming's, Foucauld Auriol-Leizagoyen, Sophie et al.

Source: Histopathology. Feb2022, Vol. 80 Issue 2, p304-313. 10p.

Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre.

Authors: Linck, Pierre-Antoine Garnier, Cassandre Depetiteville, Marie-Pierre et al.

Source: European Radiology. Mar2022, Vol. 32 Issue 3, p1644-1651. 8p.

Subjects: COVID-19, Breast cancer, Tumor growth, Diagnosis, Stay-at-home orders, Evaluation methodology, Cancer hospitals

Geographic Terms: France

Design and analysis of nested case-control studies for recurrent events subject to a terminal event.

Authors: Jazić, Ina Haneuse, Sebastien French, Benjamin et al.

Source: Statistics in Medicine. 9/30/2019, Vol. 38 Issue 22, p4348-4362. 15p.

Is It Useful to Detect Lymphovascular Invasion in Lymph Node-Positive Patients With Primary Operable Breast Cancer?

Authors: Ragage, Florence Debled, Marc MacGrogan, Gaëtan et al.

Source: Cancer (0008543X). 7/1/2010, Vol. 116 Issue 13, p3093-3101. 9p. 1 Diagram, 5 Charts, 2 Graphs.

Validation of death prediction after breast cancer relapses using joint models.

Authors: Mauguen, Audrey Rachet, Bernard Mathoulin-Pélissier, Simone et al.

Source: BMC Medical Research Methodology. 2015, Vol. 15, p1-12. 12p. 2 Charts, 5 Graphs.

PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.

Authors: Jones, Natalie Gros, Audrey Velasco, Valérie et al.

Source: Cancer Genetics. Jun2022, Vol. 264, p8-15. 8p.

Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study.

Authors: Franchet, Camille Filleron, Thomas Cayre, Anne et al.

Source: Histopathology. Feb2014, Vol. 64 Issue 2, p274-283. 10p.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Authors: Jacquemier, Jocelyne Spyratos, Frédérique Esterni, Benjamin et al.

Source: BMC Cancer. 2013, Vol. 13 Issue 1, p1-11. 11p. 4 Charts, 3 Graphs.

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Authors: Farmer, Pierre Bonnefoi, Hervé Anderle, Pascale et al.

Source: Nature Medicine. Jan2009, Vol. 15 Issue 1, p68-74. 7p. 1 Diagram, 2 Charts, 3 Graphs.

Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer.

Authors: Nicolò, Chiara Périer, Cynthia Prague, Melanie et al.

Source: JCO Clinical Cancer Informatics. 3/26/2020, Vol. 4, p259-274. 16p.

Erratum: A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.

Authors: Farmer, Pierre Bonnefoi, Hervé Anderle, Pascale et al.

Source: Nature Medicine. Feb2009, Vol. 15 Issue 2, p220-220. 1p.